SLC1A5 and melanoma: The SLC1A5 mRNA concentrations were significantly higher in the central nervous system (CNS), breast, colorectum, esophagus, stomach, head and neck, leukemia, lung, lymphoma, melanoma, myeloma, and sarcoma tissues compared with the corresponding normal tissues (Figure 1A and Supplementary Table 1).